Gudrun Boysen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Gudrun Boysen has a total of 28 co-authors. Here are the top co-authors by number of shared publications:
- Hanne Christensen
Department of Neurology, University Hospital of Copenhagen, Bispebjerg, Denmark (H.C.).
6 shared publications S Vorstrup
3 shared publicationsA Karle
2 shared publicationsA D Guassora
1 shared publicationA Voldsgaard
1 shared publicationB Sperling
Department of Neurology, University Hospital, Rigshospitalet, Copenhagen, Denmark
1 shared publication
Latest Publications
- 1 May 2003
- Published by Wolters Kluwer Health in Stroke
- Vol. 34 (5) , 1258-1261
Homocysteine and Risk of Recurrent Stroke
Background and Purpose— The goals of this work were to investigate whether elevated total homocysteine (tHcy) measured within 24 hours of acute stroke was an independent risk factor for recurrent stroke and to compare levels of tHcy in groups of patients with diagnoses of ischemic and hemorrhagic cerebrovascular events. Methods— We performed a longitudinal study of 1039 stroke patients (mean age, 75 years). Fasting tHcy was measured the morning after primary admission. Patients were followed up for 15 months. Results— Serum homocysteine was significantly higher in the 105 patients who experienced a recurrent stroke during the follow-up period than in patients without recurrence. The geometric mean±SD was 13.4±10.7 versus 11.8±7.1 μmol/L ( P =0.008), and the mean difference was 1.2 μmol/L [95% confidence interval (CI), 1.05 to 2.3]. In a multiple logistic regression model, tHcy was an independent explanatory variable of recurrent stroke within 15 months (odds ratio, 1.3; 95% CI, 1.1 to 1.5) for each increase in tHcy of 10 μmol/L. At the index event, serum homocysteine was significantly higher in 909 patients with ischemic cerebrovascular events than in 130 patients with intracerebral hemorrhage (geometric mean, 12.1±7.3 versus 10.4±5.2 μmol/L; P Conclusions— The data in this study indicate that elevated tHcy is an independent risk factor for recurrent stroke.
- 1 May 2003
- Published by Wolters Kluwer Health in Stroke
- Vol. 34 (5) , 1258-1261
Homocysteine and Risk of Recurrent Stroke
Background and Purpose— The goals of this work were to investigate whether elevated total homocysteine (tHcy) measured within 24 hours of acute stroke was an independent risk factor for recurrent stroke and to compare levels of tHcy in groups of patients with diagnoses of ischemic and hemorrhagic cerebrovascular events. Methods— We performed a longitudinal study of 1039 stroke patients (mean age, 75 years). Fasting tHcy was measured the morning after primary admission. Patients were followed up for 15 months. Results— Serum homocysteine was significantly higher in the 105 patients who experienced a recurrent stroke during the follow-up period than in patients without recurrence. The geometric mean±SD was 13.4±10.7 versus 11.8±7.1 μmol/L ( P =0.008), and the mean difference was 1.2 μmol/L [95% confidence interval (CI), 1.05 to 2.3]. In a multiple logistic regression model, tHcy was an independent explanatory variable of recurrent stroke within 15 months (odds ratio, 1.3; 95% CI, 1.1 to 1.5) for each increase in tHcy of 10 μmol/L. At the index event, serum homocysteine was significantly higher in 909 patients with ischemic cerebrovascular events than in 130 patients with intracerebral hemorrhage (geometric mean, 12.1±7.3 versus 10.4±5.2 μmol/L; P Conclusions— The data in this study indicate that elevated tHcy is an independent risk factor for recurrent stroke.
- 15 September 2002
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 201 (1-2) , 1-7
Deteriorating ischaemic stroke: cytokines, soluble cytokine receptors, ferritin, systemic blood pressure, body temperature, blood glucose, diabetes, stroke severity, and CT infarction-volume as predictors of deteriorating ischaemic stroke
- 15 September 2002
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 201 (1-2) , 1-7
Deteriorating ischaemic stroke: cytokines, soluble cytokine receptors, ferritin, systemic blood pressure, body temperature, blood glucose, diabetes, stroke severity, and CT infarction-volume as predictors of deteriorating ischaemic stroke
- 1 March 2002
- Published by Wiley in International Journal Of Clinical Practice
- Vol. 56 (2) , 82-84
ACCEPTABLE AGREEMENT BETWEEN TYMPANIC AND RECTAL TEMPERATURE IN ACUTE STROKE PATIENTS
Major concerns remain about the reliability of tympanic thermometers. The aim of this study was to investigate the agreement between rectal and tympanic thermometry and compare this with the repeatability of each method in patients with acute stroke. Tympanic temperature readings were from 0.7 degrees C below to 0.8 degrees C above rectal readings. As to repeatability, we found second rectal readings to be between 0.3 degrees C below and 0.4 degrees C above first readings, and second tympanic readings to be between 0.4 degrees C below and 0.5 degrees C above first readings. The agreement between the two methods is acceptable in clinical practice. Tympanic thermometry is useful in serial measurements, whereas, for a single accurate measurement, rectal mercury thermometry remains the method of choice.
- 1 March 2002
- Published by Wiley in International Journal Of Clinical Practice
- Vol. 56 (2) , 82-84
ACCEPTABLE AGREEMENT BETWEEN TYMPANIC AND RECTAL TEMPERATURE IN ACUTE STROKE PATIENTS
Major concerns remain about the reliability of tympanic thermometers. The aim of this study was to investigate the agreement between rectal and tympanic thermometry and compare this with the repeatability of each method in patients with acute stroke. Tympanic temperature readings were from 0.7 degrees C below to 0.8 degrees C above rectal readings. As to repeatability, we found second rectal readings to be between 0.3 degrees C below and 0.4 degrees C above first readings, and second tympanic readings to be between 0.4 degrees C below and 0.5 degrees C above first readings. The agreement between the two methods is acceptable in clinical practice. Tympanic thermometry is useful in serial measurements, whereas, for a single accurate measurement, rectal mercury thermometry remains the method of choice.
- 10 December 2001
- Vol. 163 (50) , 7057-9
[Ischemic stroke occurs among younger smokers].
Tobacco smoking is a well-known risk factor for stroke. The aim of this study was to assess whether smokers suffering ischaemic or haemorrhagic stroke differ from non-smokers in age, gender, socio-economic status, risk factors, pre-stroke level of function, and stroke severity. This work is based on 1,208 consecutive patients admitted to an acute stroke unit in a well-defined region of Copenhagen. Haemorrhagic stroke was not correlated to smoking habits. In the patients with cerebral infarctions, we found no difference between smokers and non-smokers in stroke severity on admission or outcome at three months. The smokers were younger than the non-smokers. The mean age difference between smokers and non-smokers with ischemic cerebrovascular disease was nine years (95% CI 6.9-10.4), with the highest frequencies of smokers in male patients aged below 67 years and female patients aged below 74 years. The proportion of smokers in our stroke patients was larger than that in the general population. Lower socio-economic status was also related to a younger age at the onset of stroke. This study demonstrates that stroke patients who smoke are on average nine years younger than non-smoking patients and thus emphasises the health hazards of smoking.
- 10 December 2001
- Vol. 163 (50) , 7057-9
[Ischemic stroke occurs among younger smokers].
Tobacco smoking is a well-known risk factor for stroke. The aim of this study was to assess whether smokers suffering ischaemic or haemorrhagic stroke differ from non-smokers in age, gender, socio-economic status, risk factors, pre-stroke level of function, and stroke severity. This work is based on 1,208 consecutive patients admitted to an acute stroke unit in a well-defined region of Copenhagen. Haemorrhagic stroke was not correlated to smoking habits. In the patients with cerebral infarctions, we found no difference between smokers and non-smokers in stroke severity on admission or outcome at three months. The smokers were younger than the non-smokers. The mean age difference between smokers and non-smokers with ischemic cerebrovascular disease was nine years (95% CI 6.9-10.4), with the highest frequencies of smokers in male patients aged below 67 years and female patients aged below 74 years. The proportion of smokers in our stroke patients was larger than that in the general population. Lower socio-economic status was also related to a younger age at the onset of stroke. This study demonstrates that stroke patients who smoke are on average nine years younger than non-smoking patients and thus emphasises the health hazards of smoking.
- Open Access
- 1 October 2001
- Published by Wolters Kluwer Health in Stroke
- Vol. 32 (10) , 2423-2425
Early Stroke: A Dynamic Process
- 1 October 2001
- Published by Wolters Kluwer Health in Stroke
- Vol. 32 (10) , 2423-2425
Open AccessEarly Stroke: A Dynamic Process
- 27 August 2001
- Vol. 163 (35) , 4741-4
[Thrombolytic treatment of acute cerebral infarction].
Thrombolytic therapy of acute ischaemic stroke within three hours of the onset of symptoms is approved by health authorities in the USA and Canada, but not in Europe. We report seven patients treated with recombinant tissue plasminogen activator (rtPA) within three hours of the onset of stroke according to an open protocol following internationally accepted guidelines. Three patients with initial severe neurological deficits made an almost complete recovery within the first 24 hours after treatment. Two patients had a partial remission, and two patients had no benefit. There were no bleeding complications. The present results are in accordance with the Cochrane Library's analysis of published data regarding thrombolytic therapy.
- 27 August 2001
- Vol. 163 (35) , 4741-4
[Thrombolytic treatment of acute cerebral infarction].
Thrombolytic therapy of acute ischaemic stroke within three hours of the onset of symptoms is approved by health authorities in the USA and Canada, but not in Europe. We report seven patients treated with recombinant tissue plasminogen activator (rtPA) within three hours of the onset of stroke according to an open protocol following internationally accepted guidelines. Three patients with initial severe neurological deficits made an almost complete recovery within the first 24 hours after treatment. Two patients had a partial remission, and two patients had no benefit. There were no bleeding complications. The present results are in accordance with the Cochrane Library's analysis of published data regarding thrombolytic therapy.
- 1 February 2001
- Published by Wolters Kluwer Health in Stroke
- Vol. 32 (2) , 413-417
Stroke Severity Determines Body Temperature in Acute Stroke
Background and Purpose —Several studies have claimed that temperature on admission is of prognostic significance in acute stroke. Experimental studies showing that hyperthermia increases infarct size have lent credibility to this assumption. The aim of the present study was to test the hypothesis that initial body temperature is of importance for stroke outcome. Methods —This prospective study included 725 consecutive patients, 584 with cerebral infarcts and 141 with intracerebral hemorrhages, admitted to an acute stroke unit within 6 hours of stroke onset. Time of stroke onset and time of admission were recorded. Body temperature was measured on admission and every 2 hours during the first 24 hours. Patients were divided into 2 groups on the basis of stroke severity on admission: Scandinavian Stroke Scale Score (SSS) ≤25 was defined as major stroke, and SSS >25 was defined as mild to moderate stroke. Results —On admission, mean body temperature was normal. In the major stroke patients, body temperature started to rise 4 to 6 hours after stroke onset. At 10 to 12 hours after stroke onset, increased body temperature was found to be related to poor outcome. In mild to moderate stroke, there was no significant rise in temperature. Initial temperature >37.5°C was not related to stroke severity or stroke outcome. Conclusions —In major stroke, a significant rise in temperature occurred hours after stroke onset. Severe infarcts and intracerebral hemorrhages caused temperature to rise, whereas initially increased temperature had no influence on stroke severity. Elevated body temperature on admission within 6 hours of stroke onset had no prognostic influence on stroke outcome at 3 months.
- 1 February 2001
- Published by Wolters Kluwer Health in Stroke
- Vol. 32 (2) , 413-417
Stroke Severity Determines Body Temperature in Acute Stroke
Background and Purpose —Several studies have claimed that temperature on admission is of prognostic significance in acute stroke. Experimental studies showing that hyperthermia increases infarct size have lent credibility to this assumption. The aim of the present study was to test the hypothesis that initial body temperature is of importance for stroke outcome. Methods —This prospective study included 725 consecutive patients, 584 with cerebral infarcts and 141 with intracerebral hemorrhages, admitted to an acute stroke unit within 6 hours of stroke onset. Time of stroke onset and time of admission were recorded. Body temperature was measured on admission and every 2 hours during the first 24 hours. Patients were divided into 2 groups on the basis of stroke severity on admission: Scandinavian Stroke Scale Score (SSS) ≤25 was defined as major stroke, and SSS >25 was defined as mild to moderate stroke. Results —On admission, mean body temperature was normal. In the major stroke patients, body temperature started to rise 4 to 6 hours after stroke onset. At 10 to 12 hours after stroke onset, increased body temperature was found to be related to poor outcome. In mild to moderate stroke, there was no significant rise in temperature. Initial temperature >37.5°C was not related to stroke severity or stroke outcome. Conclusions —In major stroke, a significant rise in temperature occurred hours after stroke onset. Severe infarcts and intracerebral hemorrhages caused temperature to rise, whereas initially increased temperature had no influence on stroke severity. Elevated body temperature on admission within 6 hours of stroke onset had no prognostic influence on stroke outcome at 3 months.
- 5 February 1996
- Vol. 158 (6) , 786-9
[Thrombolytic therapy in acute cerebral ischemia].
- 1 October 1993
- Published by Wolters Kluwer Health in Stroke
- Vol. 24 (10) , 1439-1446
Thrombolytic therapy in acute ischemic stroke. A Danish pilot study.
In a feasibility and safety study of thrombolytic therapy in acute ischemic stroke, we explored the usefulness of measurements of regional cerebral blood flow. Twenty-three patients with acute ischemic stroke were treated with 100 mg recombinant tissue plasminogen activator infused intravenously over 1 hour. Thrombolytic therapy was initiated 78 to 355 minutes after onset of symptoms. Angiography 16 to 24 hours after treatment in 17 patients showed patient intracranial arteries in 12, partial occlusion of the middle cerebral artery in 3, and total occlusion of the middle cerebral artery in 2. rCBF with 99mTc-hexamethylpropyleneamine oxime intravenously was measured 5 minutes before and within 24 hours after thrombolytic therapy in 12 patients. 10 of the 12 patients showed brain tissue reperfusion and 2, with angiographically documented middle cerebral artery occlusion, showed no reperfusion, thus documenting a relationship between reperfusion measured by regional cerebral blood flow and angiographic patency (P = .015). Three patients died. Patients who were reperfused within 24 hours (documented by repeated regional cerebral blood flow measurements) showed greater clinical improvement on the Scandinavian Stroke Scale the sooner their thrombolytic therapy was started and the more severe their neurological deficits. Acute cerebral ischemia can be documented by rCBF measurements without delay of thrombolytic therapy, and repeated rCBF measurements can reveal whether cerebral reperfusion has occurred. In our study, early reperfusion was associated with clinical improvement.
- 1 October 1993
- Published by Wolters Kluwer Health in Stroke
- Vol. 24 (10) , 1439-1446
Thrombolytic therapy in acute ischemic stroke. A Danish pilot study.
In a feasibility and safety study of thrombolytic therapy in acute ischemic stroke, we explored the usefulness of measurements of regional cerebral blood flow. Twenty-three patients with acute ischemic stroke were treated with 100 mg recombinant tissue plasminogen activator infused intravenously over 1 hour. Thrombolytic therapy was initiated 78 to 355 minutes after onset of symptoms. Angiography 16 to 24 hours after treatment in 17 patients showed patient intracranial arteries in 12, partial occlusion of the middle cerebral artery in 3, and total occlusion of the middle cerebral artery in 2. rCBF with 99mTc-hexamethylpropyleneamine oxime intravenously was measured 5 minutes before and within 24 hours after thrombolytic therapy in 12 patients. 10 of the 12 patients showed brain tissue reperfusion and 2, with angiographically documented middle cerebral artery occlusion, showed no reperfusion, thus documenting a relationship between reperfusion measured by regional cerebral blood flow and angiographic patency (P = .015). Three patients died. Patients who were reperfused within 24 hours (documented by repeated regional cerebral blood flow measurements) showed greater clinical improvement on the Scandinavian Stroke Scale the sooner their thrombolytic therapy was started and the more severe their neurological deficits. Acute cerebral ischemia can be documented by rCBF measurements without delay of thrombolytic therapy, and repeated rCBF measurements can reveal whether cerebral reperfusion has occurred. In our study, early reperfusion was associated with clinical improvement.
- 1 May 1988
- Published by Wolters Kluwer Health in Stroke
- Vol. 19 (5) , 654
Hemodilution in acute ischemic stroke.
- 1 May 1988
- Published by Wolters Kluwer Health in Stroke
- Vol. 19 (5) , 654
Hemodilution in acute ischemic stroke.